A recent study has investigated the initial molecular aberration in RBM20-mediated DCM, examining the effect of RBM20 point mutations using human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) [129]. Here, RBM20 is linked to familial dilated cardiomyopathy.